IPSC

Conviction 54HealthcareScan · Thu, Jun 25, 2026

IPSC$2.30+0.44%

ResistanceSupportVol 14Insider sell

Vol MA14 958.04K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Century Therapeutics, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.centurytx.com ↗

Price2.30

Change+0.44%

Gap+4.80%

Rel volume1.22×

Avg volume1M

Avg $ vol2.26M

SMA 202.25

SMA 502.28

SMA 2001.55

Price vs 50+0.68%

Price vs 200+48.55%

MA stackbullish

50/200 cross—

Supertrenddown · 2.59

RSI (14)52

MACD hist0.01

MACD crossbull · 7d

Stoch %K / %D63 / 75

ADX (14)11

+DI / −DI20 / 14

RSI divergence—

MACD divergence—

ATR %+7.20%

ADR %7.52%

52w high2.94

52w low0.4645

From 52w high-21.77%

Above 52w low+395.16%

New 52w highNo

SqueezeOn · 30d

Bollinger width17.89%

%B0.62

Donchian pos58.72%

Donchian high2.53

Donchian low1.98

AVWAP (52w high)2.32

vs AVWAP high-0.94%

AVWAP (52w low)1.86

vs AVWAP low+23.73%

OBV trendFlat

Chaikin MF (20)-0.12

Today vs 20d1.22×

Avg vol (14d)958.04K

Avg vol (20d)1M

Avg $ vol (20d)2.26M

Market cap414.82M

RS 3m (vs SPY)-10.02%

RS 6m (vs SPY)+146.71%

RS line new highNo

Trend template7/8

Technical rank79.1

1 week+2.22%

1 month+5.99%

3 months+11.11%

6 months+167.78%

1 year+286.88%

YTD+131.18%

P/E-43.30

P/B1.57

P/S3.80

P/FCF-3.96

EPS-0.1400

Div yield—

ROE-3.62%

ROA-2.93%

Debt/Eq0.01

Current10.25

EV/EBITDA—

Gross margin—

Net margin-8.78%

Rev growth1556.76%

EPS growth92.43%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value367.51M

Revenue109.16M

Net income-21.64M

Gross profit—

Free cash flow-104.72M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out180.35M

Employees78

ListedFri, Jun 18, 2021

Free float72.21M

Float %40.2%

Short interest12.47M

Days to cover13.5d

Short volume80.5%

Squeeze score83 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeC

Conviction54 / 100

Pattern quality—

Tech rank79.1 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance2.46

Support2.04

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in IPSC

All disclosures →

No recent disclosed trades by Congress in IPSC. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in IPSC · 1 buy · 5 sells

Insider	Side	Shares	Value	Traded	Filed
Russotti Gregory See Remarks · Common Stock · 2026-06-08	Sell	524	$1K	2026-06-08	2026-06-09
Russotti Gregory See Remarks · Common Stock · 2026-06-08	Other	—	—	2026-06-08	2026-06-09
Carr Douglas SVP Finance & Operations · Common Stock · 2026-06-08	Sell	249	$526	2026-06-08	2026-06-09
Pfeiffenberger Brent President and CEO · Common Stock · 2026-06-05	Tax	463	$986	2026-06-05	2026-06-09
Pfeiffenberger Brent President and CEO · Common Stock · 2026-05-15	Tax	31.17K	$73K	2026-05-15	2026-05-19
Carr Douglas SVP Finance & Operations · Common Stock · 2026-05-04	Sell	264	$618	2026-05-04	2026-05-06
Murphy Martin Patrick Director · Stock Option (right to buy) · 2025-12-09	Grant	88K	$0	2025-12-09	2026-04-10

SEC filings

EDGAR filings in IPSC · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.